These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36695663)

  • 1. Early use of tecovirimat in a young man with severe mpox skin lesions: a case report.
    Iannone V; Ciccullo A; Farinacci D; Borghetti A; Visconti E; Marchetti S; Sanguinetti M; Tamburrini E; Di Giambenedetto S
    J Med Virol; 2023 Feb; 95(2):e28528. PubMed ID: 36695663
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.
    Chen WH; Axell-House DB
    J Med Virol; 2023 Sep; 95(9):e29078. PubMed ID: 37665172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mpox in the New York metropolitan area, Summer 2022.
    Gnanaprakasam R; Keller M; Glassman R; El-Khoury MY; Chen DS; Feola N; Feldman J; Chaturvedi V
    J Med Virol; 2023 Apr; 95(4):e28699. PubMed ID: 36951318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
    Mazzotta V; Cozzi-Lepri A; Lanini S; Mondi A; Carletti F; Tavelli A; Gagliardini R; Vita S; Pinnetti C; Aguglia C; Colavita F; Faccendini P; Matusali G; Faraglia F; Beccacece A; Paulicelli J; Girardi E; Nicastri E; Vaia F; Maggi F; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28868. PubMed ID: 37306318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
    Contag CA; Mische L; Fong I; Karan A; Vaidya A; McCormick DW; Bower W; Hacker JK; Johnson K; SanJuan P; Crebbin L; Temmins C; Sahni H; Bogler Y; Cooper JD; Narasimhan S
    Emerg Infect Dis; 2023 Dec; 29(12):2520-2523. PubMed ID: 37856215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mpox Genital Lesions: A Large Single-center Experience With Intermediate Follow-up.
    Lee J; McLean J; Zucker J; Brandes S; Joice G
    J Urol; 2023 Sep; 210(3):510-516. PubMed ID: 37294043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
    Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
    PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models.
    Cinatl J; Bechtel M; Reus P; Ott M; Rothweiler F; Michaelis M; Ciesek S; Bojkova D
    J Med Virol; 2024 Jan; 96(1):e29354. PubMed ID: 38180134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Pilot of an Mpox Severity Scoring System.
    Zucker J; McLean J; Huang S; DeLaurentis C; Gunaratne S; Stoeckle K; Glesby MJ; Wilkin TJ; Fischer W; Damon I; Brooks JT
    J Infect Dis; 2024 Mar; 229(Supplement_2):S229-S233. PubMed ID: 37956401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of association between persistent skin lesion and virological replication in severe disseminated monkeypox infection in solid organ transplant recipient.
    Rousseau A; Ferrier A; Stabler S; Vuotto F; Massip E; Ouafi M; Cartier N; Ferraris O; Alidjinou EK; Faure E
    Infect Dis Now; 2023 Sep; 53(6):104749. PubMed ID: 37394180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mpox (Monkeypox) Infection During Pregnancy.
    Sampson MM; Magee G; Schrader EA; Dantuluri KL; Bukhari A; Passaretti C; Temming L; Leonard M; Philips JB; Weinrib D
    Obstet Gynecol; 2023 May; 141(5):1007-1010. PubMed ID: 36928418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations.
    Frenois-Veyrat G; Gallardo F; Gorgé O; Marcheteau E; Ferraris O; Baidaliuk A; Favier AL; Enfroy C; Holy X; Lourenco J; Khoury R; Nolent F; Grosenbach DW; Hruby DE; Ferrier A; Iseni F; Simon-Loriere E; Tournier JN
    Nat Microbiol; 2022 Dec; 7(12):1951-1955. PubMed ID: 36344621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Interactions Between Psychotropic Medications and Treatment of Mpox (tecovirimat and cidofovir).
    Mansuri Z; Shah B; Yadav G; Kainth T; Kochhar H; Srinivas S; Kamil SH; Bachu A; Reddy A
    Prim Care Companion CNS Disord; 2024 Feb; 26(1):. PubMed ID: 38382079
    [No Abstract]   [Full Text] [Related]  

  • 16. Monkeypox: NHS offers tecovirimat for severe or complicated cases.
    Mahase E
    BMJ; 2022 Sep; 378():o2272. PubMed ID: 36126983
    [No Abstract]   [Full Text] [Related]  

  • 17. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat.
    Hernandez LE; Jadoo A; Kirsner RS
    Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950
    [No Abstract]   [Full Text] [Related]  

  • 18. MPox virus: an unusual aetiology of peritonitis.
    Courdurié A; Buscot M; Gonfrier G; Courjon J; Oncioiu C; Demonchy E; Carles M
    Sex Transm Infect; 2023 Jun; 99(4):285-286. PubMed ID: 36928093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
    Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH
    JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.